
Cove Neurosciences helps researchers and clinicians extract clinically meaningful insights from brain imaging to accelerate neuroscience research and improve trial outcomes. The company provides CoveConnect™, an AI-powered, multimodal SaaS platform that analyzes EEG, MRI, and MEG data using machine learning to identify biomarkers and translate complex signals into interpretable outputs. CoveConnect integrates with research workflows and supports partnerships with pharmaceutical companies, academic institutions, and medical device firms. The platform is disease-agnostic and is used to de-risk clinical trials and accelerate R&D in brain-related disorders. Cove operates via strategic partnerships and a SaaS business model targeting institutional customers in neuroscience research.

Cove Neurosciences helps researchers and clinicians extract clinically meaningful insights from brain imaging to accelerate neuroscience research and improve trial outcomes. The company provides CoveConnect™, an AI-powered, multimodal SaaS platform that analyzes EEG, MRI, and MEG data using machine learning to identify biomarkers and translate complex signals into interpretable outputs. CoveConnect integrates with research workflows and supports partnerships with pharmaceutical companies, academic institutions, and medical device firms. The platform is disease-agnostic and is used to de-risk clinical trials and accelerate R&D in brain-related disorders. Cove operates via strategic partnerships and a SaaS business model targeting institutional customers in neuroscience research.